Hyperkalemia resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 47: | Line 47: | ||
{{familytree | | | C01 | | | | | | | | | | C02 | |C01='''Presence of [[EKG]] changes'''<br>Loss of [[P wave]]s, peaked [[T wave]]s and wide [[QRS]]<br>[[Image:EKG_hyperkalemia.gif|center|250px]]|C02='''Absence of [[EKG]] changes'''<br><br> '''and''' <br><br>'''Stable patient'''}} | {{familytree | | | C01 | | | | | | | | | | C02 | |C01='''Presence of [[EKG]] changes'''<br>Loss of [[P wave]]s, peaked [[T wave]]s and wide [[QRS]]<br>[[Image:EKG_hyperkalemia.gif|center|250px]]|C02='''Absence of [[EKG]] changes'''<br><br> '''and''' <br><br>'''Stable patient'''}} | ||
{{familytree | | | |!| | | | | | | | | | | |!| |}} | {{familytree | | | |!| | | | | | | | | | | |!| |}} | ||
{{familytree | | | D01 | | | | | | | | | | |!|D01= '''1. Myocardial stabilization'''<br>IV [[calcium lactate gluconate|Ca gluconate]] (1-2 amps)<br>Contraindicated in [[digoxin]] toxicity and hypercalcemia<br><br>'''2. Shift potassium from blood into cells'''<br>[[Insulin]] (0.2 units for every gram of glucose administered) and 20% [[dextrose]] ( 2.5-5 ml/kg/h)<br>Glucose level monitoring is needed<br><br>[[Beta2-adrenergic receptor agonist|Beta2 agonists]] ([[albuterol]] is given 10-20mg via nebulizer or 0.5 mg IV)<br><br>'''3. Lower total body potassium'''<br>[[Cation exchange resin]] ([[kayexalate]] 30-90g given P.O. or P.R.)<br><br>[[Loop diuretics]] ([[furosemide]] 1-2 mg/kg)<br><br>[[Hemodialysis]] if refractory}} | {{familytree | | | D01 | | | | | | | | | | |!|D01= '''Do the following steps simultaneously:'''<br> '''1. Myocardial stabilization'''<br>IV [[calcium lactate gluconate|Ca gluconate]] (1-2 amps)<br>Contraindicated in [[digoxin]] toxicity and hypercalcemia<br><br>'''2. Shift potassium from blood into cells'''<br>[[Insulin]] (0.2 units for every gram of glucose administered) and 20% [[dextrose]] ( 2.5-5 ml/kg/h)<br>Glucose level monitoring is needed<br><br>[[Beta2-adrenergic receptor agonist|Beta2 agonists]] ([[albuterol]] is given 10-20mg via nebulizer or 0.5 mg IV)<br><br>'''3. Lower total body potassium'''<br>[[Cation exchange resin]] ([[kayexalate]] 30-90g given P.O. or P.R.)<br><br>[[Loop diuretics]] ([[furosemide]] 1-2 mg/kg)<br><br>[[Hemodialysis]] if refractory}} | ||
{{familytree | | | |:| | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|.|}} | {{familytree | | | |:| | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|.|}} | ||
{{familytree | | | |:| | | | E01 | | | | | | | | | | | E02 |E01='''Potassium > 6 mEq/L'''|E02= '''5.5mEq/L<Potassium<6mEq/L'''}} | {{familytree | | | |:| | | | E01 | | | | | | | | | | | E02 |E01='''Potassium > 6 mEq/L'''|E02= '''5.5mEq/L<Potassium<6mEq/L'''}} | ||
{{familytree | | | |:| | | | |!| | | | | | | | | | | | |!| | | | }} | {{familytree | | | |:| | | | |!| | | | | | | | | | | | |!| | | | }} | ||
{{familytree | | | |:| | | | F01 | | | | | | | | | | | F02 | |F01='''1. Monitor for cardiac arrhythmia'''<br>Place the patient on a closely monitored bed for potential [[arrhythmia]]s<br><br>'''2. Shift potassium from blood into cells'''<br>[[Insulin]] (0.2 units for every gram of [[glucose]] administered) and 20%[[dextrose]] ( 2.5-5 ml/kg/h)<br>Glucose level monitoring is needed<br><br>[[Beta2-adrenergic receptor agonist|Beta2 agonists]] ([[albuterol]] is given 10-20mg via nebulizer or 0.5 mg IV)<br><br>'''3. Lower total body potassium'''<br>[[Cation exchange resin]] ([[kayexalate]] 30-90g given P.O. or P.R.<br>[[Loop diuretics]] ([[furosemide]] 1-2 mg/kg)<br><br>[[Hemodialysis]] if refractory|F02='''Lower total body potassium'''<br>[[Cation exchange resin]] ([[kayexalate]] 30-90g given P.O. or P.R.)<br><br>[[Loop diuretics]] ([[furosemide]] 1-2 mg/kg)}} | {{familytree | | | |:| | | | F01 | | | | | | | | | | | F02 | |F01=''''''Do the following steps simultaneously:'''<br>1. Monitor for cardiac arrhythmia'''<br>Place the patient on a closely monitored bed for potential [[arrhythmia]]s<br><br>'''2. Shift potassium from blood into cells'''<br>[[Insulin]] (0.2 units for every gram of [[glucose]] administered) and 20%[[dextrose]] ( 2.5-5 ml/kg/h)<br>Glucose level monitoring is needed<br><br>[[Beta2-adrenergic receptor agonist|Beta2 agonists]] ([[albuterol]] is given 10-20mg via nebulizer or 0.5 mg IV)<br><br>'''3. Lower total body potassium'''<br>[[Cation exchange resin]] ([[kayexalate]] 30-90g given P.O. or P.R.<br>[[Loop diuretics]] ([[furosemide]] 1-2 mg/kg)<br><br>[[Hemodialysis]] if refractory|F02='''Lower total body potassium'''<br>[[Cation exchange resin]] ([[kayexalate]] 30-90g given P.O. or P.R.)<br><br>[[Loop diuretics]] ([[furosemide]] 1-2 mg/kg)}} | ||
{{familytree | | | |:| | | | |:| | | | | | | | | | | | |:| | | | }} | {{familytree | | | |:| | | | |:| | | | | | | | | | | | |:| | | | }} | ||
{{familytree | | | |L|~|~|~|~|%|~|~|~|~|~|~|~|~|~|~|~|~|J| | | }} | {{familytree | | | |L|~|~|~|~|%|~|~|~|~|~|~|~|~|~|~|~|~|J| | | }} |
Revision as of 13:00, 28 July 2013
Hyperkalemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hyperkalemia resident survival guide On the Web |
American Roentgen Ray Society Images of Hyperkalemia resident survival guide |
Risk calculators and risk factors for Hyperkalemia resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mahmoud Sakr, M.D. [2]; Rim Halaby
For hyperkalemia smart algorithm click here
Definition
Hyperkalemia is defined as a serum potassium concentration greater than 5.5 mEq/L in adults. Levels higher than 7 mEq/L can lead to significant hemodynamic compromise.
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.
- Acute renal failure
- Adrenal insufficiency
- Diabetic ketoacidosis
- Large IV doses of calcium chloride or calcium gluconate
- Massive hemolysis
- Metabolic acidosis
- Rapid tissue necrosis
- Rhabdomyolysis
- Tumor lysis syndrome
Common Causes
- Adrenal insufficiency
- Blood transfusion
- Diabetic ketoacidosis
- Potassium supplementation (oral or IV)
- Potassium rich diet
- Medications: ACE inhibitors, angiotensin receptor blockers, amiloride, spironolactone, NSAIDS, ciclosporin, tacrolimus, trimethoprim, pentamidine, succinylcholine
- Pseudohyperkalemia
- Renal insufficiency
- Renal tubular acidosis type 4
Management
Shown below is an algorithm summarizing the approach to hyperkalemia.[1][2][3]
Potassium > 5.5 mEq/L | |||||||||||||||||||||||||||||||||||||||||||||||||||
If repeated potassium level is normal, check potassium level in 24 hours | R/O Pseudohyperkalemia (Artifact, hemolysis, elevated WBC, elevated RBC, elevated platelets) Repeat potassium level | ||||||||||||||||||||||||||||||||||||||||||||||||||
Check vital signs ABC's Order an EKG Obtain a concise history and physical exam Order BUN, creatinine, glucose, ABG | |||||||||||||||||||||||||||||||||||||||||||||||||||
Assess EKG | |||||||||||||||||||||||||||||||||||||||||||||||||||
Presence of EKG changes Loss of P waves, peaked T waves and wide QRS | Absence of EKG changes and Stable patient | ||||||||||||||||||||||||||||||||||||||||||||||||||
Do the following steps simultaneously: 1. Myocardial stabilization IV Ca gluconate (1-2 amps) Contraindicated in digoxin toxicity and hypercalcemia 2. Shift potassium from blood into cells Insulin (0.2 units for every gram of glucose administered) and 20% dextrose ( 2.5-5 ml/kg/h) Glucose level monitoring is needed Beta2 agonists (albuterol is given 10-20mg via nebulizer or 0.5 mg IV) 3. Lower total body potassium Cation exchange resin (kayexalate 30-90g given P.O. or P.R.) Loop diuretics (furosemide 1-2 mg/kg) Hemodialysis if refractory | |||||||||||||||||||||||||||||||||||||||||||||||||||
Potassium > 6 mEq/L | 5.5mEq/L<Potassium<6mEq/L | ||||||||||||||||||||||||||||||||||||||||||||||||||
'Do the following steps simultaneously:' 1. Monitor for cardiac arrhythmia Place the patient on a closely monitored bed for potential arrhythmias 2. Shift potassium from blood into cells Insulin (0.2 units for every gram of glucose administered) and 20%dextrose ( 2.5-5 ml/kg/h) Glucose level monitoring is needed Beta2 agonists (albuterol is given 10-20mg via nebulizer or 0.5 mg IV) 3. Lower total body potassium Cation exchange resin (kayexalate 30-90g given P.O. or P.R. Loop diuretics (furosemide 1-2 mg/kg) Hemodialysis if refractory | Lower total body potassium Cation exchange resin (kayexalate 30-90g given P.O. or P.R.) Loop diuretics (furosemide 1-2 mg/kg) | ||||||||||||||||||||||||||||||||||||||||||||||||||
D/C any offending medications that is associated with hyperkalemia D/C oral or parenteral potassium Correct acidosis with bicarb if pH<7.2 Restrict dietary potassium intake Review potassium levels every 2-4 hours until stabilized Check levels of other electrolytes such as magnesium and phosphorus | |||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Lehnhardt A, Kemper MJ (2011). "Pathogenesis, diagnosis and management of hyperkalemia". Pediatr Nephrol. 26 (3): 377–84. doi:10.1007/s00467-010-1699-3. PMC 3061004. PMID 21181208.
- ↑ Ahee P. The management of hyperkalaemia in the emergency department. J Accid Emerg Med 2000;17:188-191 doi:10.1136/emj.17.3.18
- ↑ Weisberg L. Management of severe hyperkalemia. Crit Care Med 2008 Vol. 36, No. 12.